{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:31:31Z","timestamp":1784068291535,"version":"3.55.0"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"3","funder":[{"DOI":"10.13039\/100011102","name":"European Union Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"European Union Seventh Framework Programme","doi-asserted-by":"publisher","award":["279277"],"award-info":[{"award-number":["279277"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/ndt\/gfx068","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T06:19:19Z","timestamp":1491373159000},"page":"441-449","source":"Crossref","is-referenced-by-count":46,"title":["Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion"],"prefix":"10.1093","volume":"33","author":[{"given":"Elena","family":"Critselis","sequence":"first","affiliation":[{"name":"Proteomics Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Vlahou","sequence":"additional","affiliation":[{"name":"Proteomics Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vianda S","family":"Stel","sequence":"additional","affiliation":[{"name":"ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael L","family":"Morton","sequence":"additional","affiliation":[{"name":"National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,3]]},"reference":[{"key":"key\n\t\t\t\t20180305025527_gfx068-B1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B2","first-page":"418","article-title":"The global burden of chronic kidney disease and the way forward","volume":"15","author":"Alebiosu","year":"2005","journal-title":"Ethn Dis"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B3","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1681\/ASN.2015050542","article-title":"CKD prevalence varies across the European general population","volume":"27","author":"Bruck","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B4","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B5","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1681\/ASN.V13suppl_1s37","article-title":"Maintenance dialysis population dynamics: current trends and long-term implications","volume":"13(Suppl 1)","author":"Lysaght","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B6","author":"World Health Organization","year":"2008"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B7","volume-title":"Global Health Estimates: Deaths by Cause, Age, Sex and Country, 2000-2012","author":"World Health Organization","year":"2014"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B8","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1681\/ASN.2012040392","article-title":"Medical costs of CKD in the Medicare population","volume":"24","author":"Honeycutt","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B9","first-page":"5","article-title":"The long path towards implementation of clinical proteomics: exemplified based on CKD273","volume":"11","author":"Nkuipou-Kenfack","year":"2017","journal-title":"Proteomics Clin Appl"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/imj.12797","article-title":"Cost to government and society of chronic kidney disease stage 1-5: a national cohort study","volume":"45","author":"Wyld","year":"2015","journal-title":"Intern Med J"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B11","doi-asserted-by":"crossref","first-page":"iv113","DOI":"10.1093\/ndt\/gfv073","article-title":"Prediction of prevalence of chronic kidney disease in diabetic patients in countries of the European Union up to 2025","volume":"30(Suppl 4)","author":"Kainz","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"Levey","year":"2012","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.ki.5002343","article-title":"Chronic kidney disease as a global public health problem: approaches and initiatives \u2013 a position statement from Kidney Disease Improving Global Outcomes","volume":"72","author":"Levey","year":"2007","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrneph.2015.85","article-title":"Early chronic kidney disease: diagnosis, management and models of care","volume":"11","author":"Wouters","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B15","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B16","doi-asserted-by":"crossref","first-page":"f324","DOI":"10.1136\/bmj.f324","article-title":"Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis","volume":"346","author":"Nitsch","year":"2013","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1373\/clinchem.2008.106567","article-title":"Current issues in measurement and reporting of urinary albumin excretion","volume":"55","author":"Miller","year":"2009","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/MNH.0b013e32834b7ffa","article-title":"Urinary proteomics in the assessment of chronic kidney disease","volume":"20","author":"Mullen","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B19","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2337\/dc15-0184","article-title":"Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes","volume":"38","author":"Krolewski","year":"2015","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B20","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1074\/mcp.M110.001917","article-title":"Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease","volume":"9","author":"Good","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B21","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/ndt\/gfu039","article-title":"Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy","volume":"29","author":"Siwy","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B22","first-page":"249","article-title":"Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression","volume":"31","author":"Critselis","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cca.2013.09.018","article-title":"From biomarkers to medical tests: the changing landscape of test evaluation","volume":"427","author":"Horvath","year":"2014","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.ackd.2010.09.004","article-title":"Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application","volume":"17","author":"Mischak","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B25","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1126\/science.1211811","article-title":"Improving validation practices in \"omics\" research","volume":"334","author":"Ioannidis","year":"2011","journal-title":"Science"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B26","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1016\/j.jprot.2012.07.024","article-title":"A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases","volume":"75","author":"Molin","year":"2012","journal-title":"J Proteomics"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B27","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.2337\/diab.46.2.S104","article-title":"How to protect the kidney in diabetic patients: with special reference to IDDM","volume":"46(Suppl 2)","author":"Mogensen","year":"1997","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.ajkd.2009.11.017","article-title":"A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening","volume":"55","author":"Hoerger","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B29","doi-asserted-by":"crossref","first-page":"f1049","DOI":"10.1136\/bmj.f1049","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"346","author":"Husereau","year":"2013","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18140","article-title":"Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment \u2013 systematic review and modelling of progression and cost-effectiveness","volume":"18","author":"Farmer","year":"2014","journal-title":"Health Technol Assess"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B31","doi-asserted-by":"crossref","first-page":"e1001307","DOI":"10.1371\/journal.pmed.1001307","article-title":"A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments","volume":"9","author":"Wyld","year":"2012","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","article-title":"Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)","volume":"63","author":"Adler","year":"2003","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B33","doi-asserted-by":"crossref","first-page":"c5869","DOI":"10.1136\/bmj.c5869","article-title":"Population based screening for chronic kidney disease: cost effectiveness study","volume":"341","author":"Manns","year":"2010","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B34","first-page":"iii32","article-title":"The impact of CKD identification in large countries: the burden of illness","volume":"27(Suppl 3)","author":"Jha","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B35","article-title":"The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry","author":"Pippias","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/ckj\/sfv035","article-title":"2012 ERA-EDTA Registry Annual Report: cautious optimism on outcomes, concern about persistent inequalities and data black-outs","volume":"8","author":"Gonzalez-Espinoza","year":"2015","journal-title":"Clin Kidney J"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijcard.2014.01.065","article-title":"Reduction of albumin urinary excretion is associated with reduced cardiovascular events in hypertensive and\/or diabetic patients. A meta-regression analysis of 32 randomized trials","volume":"172","author":"Savarese","year":"2014","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B38","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/db05-1620","article-title":"Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74","volume":"55","author":"Retnakaran","year":"2006","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B39","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1185\/03007995.2015.1041895","article-title":"Utility values in diabetic kidney disease: a literature review","volume":"31","author":"Kennedy-Martin","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B40","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s11136-011-9902-y","article-title":"A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation","volume":"20","author":"Lung","year":"2011","journal-title":"Qual Life Res"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-6296(86)90020-2","article-title":"Measurement of health state utilities for economic appraisal","volume":"5","author":"Torrance","year":"1986","journal-title":"J Health Econ"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/680737","article-title":"Chronic kidney disease: evolution of healthcare costs and resource consumption from predialysis to dialysis in Piedmont region, Italy","volume":"2014","author":"Roggeri","year":"2014","journal-title":"Adv Nephrol"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B43","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1001\/jama.294.20.2618","article-title":"Quality, innovation, and value for money: NICE and the British National Health Service","volume":"294","author":"Pearson","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B44","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/ndt\/gfp174","article-title":"The cost-effectiveness of induction immunosuppression in kidney transplantation","volume":"24","author":"Morton","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B45","volume-title":"The Guidelines Manual","author":"National Institute for Health and Care Excellence","year":"2012"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B46","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jval.2012.04.012","article-title":"Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7","volume":"15","author":"Eddy","year":"2012","journal-title":"Value Health"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B47","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-013-2940-y","article-title":"UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30\u2009year United Kingdom Prospective Diabetes Study: UKPDS 82","volume":"56","author":"Hayes","year":"2013","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B48","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2165\/00019053-200017050-00007","article-title":"Testing the validity of cost-effectiveness models","volume":"17","author":"McCabe","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/dom.12583","article-title":"Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes","volume":"18","author":"Schievink","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B50","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ki.2010.536","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts","volume":"79","author":"van der Velde","year":"2011","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B51","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/ki.2010.550","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts","volume":"79","author":"Astor","year":"2011","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B52","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.2337\/db12-0348","article-title":"Urinary proteomics for early diagnosis in diabetic nephropathy","volume":"61","author":"Zurbig","year":"2012","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00125-012-2755-2","article-title":"A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus","volume":"56","author":"Roscioni","year":"2013","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B54","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1053\/j.ajkd.2013.12.012","article-title":"Cost-effectiveness of primary screening for CKD: a systematic review","volume":"63","author":"Komenda","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B55","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11606-010-1511-x","article-title":"Chronic kidney disease and the risk of end-stage renal disease versus death","volume":"26","author":"Dalrymple","year":"2011","journal-title":"J Gen Intern Med"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B56","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1681\/ASN.2012040347","article-title":"Cost-effectiveness of screening for microalbuminuria among African Americans","volume":"23","author":"Hoerger","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B57","first-page":"CD007333","article-title":"Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease","volume":"6","author":"Smart","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B58","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/ndt\/15.12.1900","article-title":"Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment?","volume":"15","author":"Ruggenenti","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000382028","article-title":"Prevalence and management of diabetic nephropathy in western countries","volume":"1","author":"Satirapoj","year":"2015","journal-title":"Kidney Dis (Basel)"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B60","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/dme.12312","article-title":"Chronic kidney disease and diabetes in the national health service: a cross-sectional survey of the U.K. national diabetes audit","volume":"31","author":"Hill","year":"2014","journal-title":"Diabet Med"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B61","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1464-5491.2010.03049.x","article-title":"Comparison of the prevalence of chronic kidney disease in Japanese patients with type 1 and type 2 diabetes","volume":"27","author":"Ohta","year":"2010","journal-title":"Diabet Med"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B62","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11906-002-0069-3","article-title":"Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy","volume":"4","author":"Parving","year":"2002","journal-title":"Curr Hypertens Rep"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B63","doi-asserted-by":"crossref","first-page":"e005480","DOI":"10.1136\/bmjopen-2014-005480","article-title":"Change in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010","volume":"4","author":"Aitken","year":"2014","journal-title":"BMJ Open"},{"key":"key\n\t\t\t\t20180305025527_gfx068-B64","first-page":"S1","article-title":"US Renal Data System 2014 Annual Data Report: epidemiology of kidney disease in the United States","volume":"66(1 Suppl 1)","author":"Saran","year":"2015","journal-title":"Am J Kidney Dis"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/33\/3\/441\/24196422\/gfx068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T06:07:38Z","timestamp":1658902058000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/33\/3\/441\/3920591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,3]]},"references-count":64,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,7,3]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfx068","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2017,7,3]]}}}